What happens if an Office employee identifies a patent that may warrant reexamination?

If a USPTO employee identifies a patent that they believe clearly warrants reexamination, there is a specific internal process to follow. According to MPEP 2239: “If an Office employee becomes aware of an unusual fact situation in a patent which the employee considers to clearly warrant reexamination, a memorandum setting forth these facts (including a…

Read More

How does the USPTO handle correspondence information submitted through EFS-Web for international design applications?

For international design applications, the USPTO may use correspondence information submitted through EFS-Web in certain situations. According to MPEP 2912: “Where no correspondence information is included in the submission, or the correspondence information was not made in accordance with the applicable regulations, the Office may use application data furnished through EFS-Web for purposes of correspondence…

Read More

How does the USPTO determine the effective filing date for foreign priority claims?

For U.S. patent documents claiming foreign priority, the USPTO determines the effective filing date based on the description of the subject matter in the foreign application. MPEP 2154.01(b) states: If subject matter of a U.S. patent document under examination is not described in the earliest application to which benefit or priority is claimed, the effective…

Read More

Can the Director make exceptions to the “special dispatch” requirement in inter partes reexamination?

Yes, the Director of the USPTO can make exceptions to the “special dispatch” requirement in inter partes reexamination proceedings for good cause. This is explicitly stated in 35 U.S.C. 314(c): “Unless otherwise provided by the Director for good cause, all inter partes reexamination proceedings under this section, including any appeal to the Board of Patent…

Read More

How does the USPTO determine if a biological deposit is necessary for a patent application?

The necessity of a biological deposit is determined on a case-by-case basis by the USPTO. According to MPEP 2403: “For the most part, this issue must be addressed on a case-by-case basis.” The examiner evaluates whether the deposit is needed to satisfy the statutory requirements for patentability, particularly the enablement requirement under 35 U.S.C. 112(a).…

Read More

How does the USPTO determine if the written description requirement is met?

The USPTO determines if the written description requirement is met through a case-by-case analysis. According to MPEP 2163.02: “The fundamental factual inquiry is whether the specification conveys with reasonable clarity to those skilled in the art that, as of the filing date sought, applicant was in possession of the invention as now claimed.” This assessment…

Read More